To uncover the molecular pathogenic mechanism of congenital osteogenesis imperfecta (OI) type I, all the 103 exons of the COL1A1 (Collagen, type Ⅰ, alpha 1) and COL1A2 (Collagen, type Ⅰ, alpha 2) genes in a child with OI type Ⅰ were screened using PCR-DNA direct sequencing. The results showed no pathological mutation in COL1A1 gene, but a novel mutation c.946G>T/p.G316C in the exon 19 of COL1A2 gene, which was inherited from her father. This mutation was not found in her mother and other six phenotypically normal relatives. By denaturing high performance liquid chromatography (DHPLC) screening, the abnormal double-peak was visualized in PCR products of exon 19 of COL1A2 gene in the proband and her father, while the normal single-peak was shown in those of her mother and all the healthy controls. Using allele specific amplification (ASA) screening, a specific band of 391 bp in COL1A2 exon 19 was amplified only in the proband and her father, but not in other samples. The amino acid encoded by the mutation site is evolutionarily highly conserved, and this mutation was a “damaging” or “probably damaging” factor to OI type Ⅰ, based on the predicting results using SIFT and Polyphen-2 softwares. In conclusion, the novel c.946G>T/p.G316C mutation in COL1A2 gene is a pathogenic mutation that could result in OI type Ⅰ. If the couple wants to get pregnant again, it is necessary to screen the mutation site in COL1A2 gene through the prenatal genetic diagnosis in the first trimester or through preimplantation genetic diagnosis (PGD) in the progestation.
Rong Li, Yuanping Guo, Jingxin Pan, Yibin Guo
. Genetic screening of a pedigree with osteogenesis imperfecta type Ⅰ and identification of a novel mutation in COL1A2 pathogenic gene[J]. Hereditas(Beijing), 2015
, 37(1)
: 41
-47
.
DOI: 10.16288/j.yczz.2015.01.006
[1] 徐超, 韩金祥, 鲁艳芹. 成骨不全的分子机制. 中国生物化学与分子生物学报, 2012, 28(4): 310-315.
[2] Osteogenesis Imperfecta, Type XV; OI15. http://omim.org/ entry/615220.
[3] Fahiminiya S, Majewski J, Mort J, Moffatt P, Glorieux FH, Rauch F. Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet , 2013, 50(5): 345-348.
[4] Byers PH, Cole WG. Osteogenesis imperfecta. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects. New York: Wiley-Liss, 2002: 385-430.
[5] Gajko-Galicka A. Mutations in type Ⅰ collagen genes resulting in osteogenesis imperfecta in humans. Acta Biochim Pol , 2002, 49(2): 433-441.
[6] 吴晓林, 顾鸣敏, 崔斌, 李西华, 袁文涛, 陆振虞, 宋怀东, 王铸钢. 一例Ⅰ型成骨不全家系的基因定位及突变检测. 上海交通大学学报 (医学版), 2007, 27(6): 699-702.
[7] 唐佳, 潘敬新, 蒋玮莹, 郭奕斌. 一例抗维生素D佝偻病的基因诊断和新突变的致病性鉴定. 中华临床医师杂志 (电子版), 2012, 6(5): 1226-1230.
[8] 王卓, 徐栋梁, 胡俊勇, 廖悦华, 杨峥, 梁琼, 王连唐. 成骨不全一家系的 COL1A1 基因突变分析. 中华医学遗传学杂志, 2006, 23(2): 192-194.
[9] 王熙然. 成骨不全家系临床及基因特征研究[学位论文]. 北京: 中国人民解放军军医进修学院, 2008: 20-24.
[10] 艾阳, 唐佳, 方群, 吴晓昀, 郭奕斌. 一例成骨不全Ⅱ型高危胎儿的产前基因诊断. 中华临床医师杂志 (电子版), 2011, 5(22): 6662-6666.
[11] 郭奕斌, 艾阳, 蒋玮莹. 一罕见成骨不全Ⅳ型的基因诊断. 分子诊断与治疗杂志, 2013, 5(1): 12-14.
[12] Vandersteen AM, Lund AM, Ferguson DJP, Sawle P, Pollitt RC, Holder SE, Wakeling E, Moat N, Pope FM. Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations. Am J Med Genet A , 2014, 164(2): 386-391.
[13] Peng H, Zhang YH, Long ZG, Zhao D, Guo ZX, Xue JJ, Xie ZG, Xiong ZM, Xu XJ, Su W, Wang B, Xia K, Hu ZM. A novel splicing mutation in COL1A1 gene caused type I osteogenesis imperfecta in a Chinese family. Gene , 2012, 502(2): 168-171.
[14] Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat , 2007, 28(3): 209-221.
[15] Gentile FV, Zuntini M, Parra A, Battistelli L, Pandolfi M, Pals G, Sangiorgi L. Validation of a quantitative PCR- high-resolution melting protocol for simultaneous screening of COL1A1 and COL1A2 point mutations and large rearrangements: application for diagnosis of osteogenesis imperfecta. Hum Mutat , 2012, 33(12): 1697-1707.
